Berkowitz Noah
Chief Medical Officer · 5 filings · Latest: Sep 30, 2026
ARVINAS, INC.
IOVANCE BIOTHERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARVN | NOAH C BERKOWITZ | — | Sep 9, 2026 | Proposed Sale | $8.84 | 37,200 | $328.9K | — | |
ARVN | NOAH C BERKOWITZ | — | Sep 4, 2026 | Proposed Sale | $9.45 | 8,300 | $78.4K | — | |
ARVN | NOAH C BERKOWITZ | — | Aug 4, 2026 | Proposed Sale | $8.80 | 30,000 | $264.0K | — | |
ARVN | NOAH C BERKOWITZ | — | Jul 9, 2026 | Proposed Sale | $8.40 | 24,000 | $201.5K | — | |
ARVN | Berkowitz Noah | Chief Medical Officer | May 11, 2026 | Sale | $9.94 | 11,108 | $110.4K | 191,395 | |
ARVN | Noah Berkowitz | — | May 11, 2026 | Proposed Sale | $10.11 | 11,312 | $114.4K | — | |
ARVN | Berkowitz Noah | Chief Medical Officer | Mar 18, 2026 | Sale | $11.10 | 6,435 | $71.4K | 202,503 | |
ARVN | Noah Berkowitz | — | Mar 18, 2026 | Proposed Sale | $12.01 | 6,022 | $72.3K | — | |
ARVN | Berkowitz Noah | Chief Medical Officer | Feb 13, 2026 | Sale | $11.89 | 5,685 | $67.6K | 163,938 | |
ARVN | Noah Berkowitz | — | Feb 13, 2026 | Proposed Sale | $11.89 | 5,685 | $67.6K | — | |
ARVN | Noah Berkowitz | — | Mar 18, 2025 | Proposed Sale | $8.59 | 8,658 | $74.4K | — |